Abstract：
Objectives We investigated the current perspectives regarding the management of late-onset rheumatoid arthritis (LORA) among rheumatologists in clinical practice. Methods This study was performed in October 2021, and included 65 rheumatologists certified by the Japan College of Rheumatology, who were administered questionnaires (including multiple choice and descriptive formulae) regarding the management of LORA. We aggregated and analyzed the responses. Results All 65 rheumatologists responded to the survey; 47 (72%) answered that >50% of newly diagnosed patients were aged ≥65 years, 42 (65%) answered that achievement of remission or low disease activity was the treatment goal, and 40 (62%) considered patient safety to be the highest priority. Most rheumatologists are concerned about the management of conditions other than RA, such as comorbidities, financial constraints, and life circumstances that interfere with standard or recommended treatment implementation. Conclusion This preliminary survey highlighted various rheumatologists\' perspectives regarding the management of LORA.
摘要：
目的我们调查了风湿病学家在临床实践中对迟发性类风湿关节炎（LORA）的管理的当前观点。方法本研究于2021年10月进行，包括由日本风湿病学会认证的65名风湿病学家，他们接受了关于LORA管理的问卷(包括多项选择和描述性公式)。我们汇总并分析了答复。结果65位风湿病专家均对调查做出回应；47位（72％）回答>50％的新诊断患者年龄≥65岁，42（65％）回答说，实现缓解或低疾病活动是治疗目标，和40（62％）认为患者安全是最高优先级。大多数风湿病学家都关心RA以外的疾病的管理，如合并症，财政限制，以及干扰标准或推荐治疗实施的生活环境。结论这项初步调查强调了各种风湿病学家对LORA管理的看法。
